BANK OF AMERICA CORP /DE/ - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 38 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$134
-44.2%
7080.0%0.00%
Q1 2023$240
+110.5%
708
+100.0%
0.00%
Q4 2022$114
-88.6%
354
-72.0%
0.00%
Q3 2022$1,0000.0%1,266
-61.0%
0.00%
Q2 2022$1,000
-91.7%
3,248
-65.5%
0.00%
Q1 2022$12,000
-40.0%
9,401
-37.8%
0.00%
Q4 2021$20,000
-56.5%
15,117
-32.2%
0.00%
Q3 2021$46,000
-2.1%
22,283
-25.6%
0.00%
Q2 2021$47,000
-75.8%
29,947
-65.7%
0.00%
Q1 2021$194,000
+110.9%
87,392
+136.6%
0.00%
Q4 2020$92,000
+39.4%
36,938
+36.8%
0.00%
Q3 2020$66,000
-76.0%
27,000
-65.2%
0.00%
Q2 2020$275,000
+76.3%
77,499
+16.3%
0.00%
Q1 2020$156,000
-34.7%
66,654
-38.7%
0.00%
Q4 2019$239,000
+1.7%
108,764
-15.2%
0.00%
Q3 2019$235,000
-23.7%
128,201
-39.6%
0.00%
Q2 2019$308,000
+17.1%
212,288
+59.1%
0.00%
Q1 2019$263,000
+34.9%
133,391
-10.1%
0.00%
Q4 2018$195,000
+23.4%
148,443
+130.1%
0.00%
Q3 2018$158,000
-19.8%
64,518
+10.1%
0.00%
Q2 2018$197,000
+497.0%
58,623
+648.6%
0.00%
Q1 2018$33,000
+3.1%
7,831
-19.7%
0.00%
Q4 2017$32,000
+23.1%
9,752
+45.2%
0.00%
Q3 2017$26,000
-35.0%
6,718
-25.8%
0.00%
Q2 2017$40,000
+21.2%
9,0540.0%0.00%
Q1 2017$33,000
+135.7%
9,054
+70.8%
0.00%
Q4 2016$14,000
-17.6%
5,3000.0%0.00%
Q3 2016$17,000
-51.4%
5,300
-48.5%
0.00%
Q2 2016$35,000
+2.9%
10,300
-26.7%
0.00%
Q1 2016$34,000
-57.0%
14,054
-41.6%
0.00%
Q4 2015$79,00024,0540.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q2 2022
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$89,0000.08%
Geier Asset Management, Inc. 35,000$91,0000.07%
Patriot Financial Group Insurance Agency, LLC 43,250$107,0000.03%
Willow Creek Wealth Management Inc. 24,224$60,0000.02%
WEBSTER BANK, N. A. 70,000$174,0000.02%
Brown Advisory Securities, LLC 28,000$69,0000.01%
Cubic Asset Management, LLC 11,250$28,0000.01%
Tower Research Capital LLC (TRC) 25,613$64,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 25,000$62,0000.00%
Sterling Investment Advisors, Ltd. 2,500$6,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders